Phase I Clinical Study of the Dietary Supplement, Agaricus blazei Murill, in Cancer Patients in Remission

Although many cancer patients use complementary and alternative medicine, including Agaricus blazei Murill (ABM), safety is not yet well understood. Cancer survivors took 1.8, 3.6, or 5.4 g ABM granulated powder (Kyowa Wellness Co., Ltd., Tokyo, Japan) per day orally for 6 months. Adverse events wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohno, Satoshi, Sumiyoshi, Yoshiteru, Hashine, Katsuyoshi, Shirato, Akitomi, Kyo, Satoru, Inoue, Masaki
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092499/
https://www.ncbi.nlm.nih.gov/pubmed/21584278
http://dx.doi.org/10.1155/2011/192381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092499/
https://www.ncbi.nlm.nih.gov/pubmed/21584278
http://dx.doi.org/10.1155/2011/192381

Ejemplares similares